Onpattro 10 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DR26FMDT4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,377
Award facts
- Contract value 100% obligated
- $28,376.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,376.64 to DMS Pharmaceutical Group Inc. for ONPATTRO 10 mg/5 ml vials on October 27, 2025. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, specializing in distributing a comprehensive range of pharmaceutical products and medical consumables to federal agencies. This delivery order was issued without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The contract utilizes firm fixed pricing and carries an ultimate completion date of November 18, 2025.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor for pharmaceutical supply to military healthcare facilities worldwide. Through this vehicle, the company delivers an extensive portfolio including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FMDT4?
SPE2DR26FMDT4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FMDT4 worth?
The government has obligated $28,377 on SPE2DR26FMDT4.
Is contract SPE2DR26FMDT4 an order under another contract?
Yes. SPE2DR26FMDT4 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDT4 competed?
The extent of competition for SPE2DR26FMDT4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award